Discontinuation report EPTIFIBATIDE INJECTION
Report ID | 14027 |
Drug Identification Number | 02367858 |
Brand name | EPTIFIBATIDE INJECTION |
Common or Proper name | EPTIFIBATIDE |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | EPTIFIBATIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10ML |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-03-03 |
Remaining supply date | 2017-03-03 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-06-27 | French | Compare |
v1 | 2017-06-27 | English | Compare |
Showing 1 to 2 of 2